ArticlePediatric research2026
The potential role of miR-34a and miR-34c in the regulation of pediatric high-grade glioma 4 aggressiveness.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric diffuse high-grade gliomas grade 4 (pHGG-4), the most aggressive malignant primary brain tumors, are incurable and associated with poor prognosis. In most pHGG-4, meaningful genetic aberrations were rarely found, and the aggressiveness is derived from epigenetic changes and dysregulated gene expression. miRNAs are significant epigenetic regulators of gene expression that play important roles in many cancers.
methodsmiR-34a and miR-34c levels were analyzed in pHGG cell lines and tumor datasets. SF188 and KNS42 cells were transfected with miR-34a/miR-34c mimic or scrambled oligonucleotide, and examined for viability, migration ability, and invasiveness. Expression of survival, cell cycle arrest/progression, apoptosis, and Epithelial-Mesenchymal Transition (EMT) regulating genes was examined using quantitative PCR (qPCR), western blot, and immunofluorescence assays.
resultsmiR-34a and miR-34c were scarcely expressed in pHGG-4 cell lines, and miR-34c was downregulated in pHGG-4 tumor datasets. Upregulating miR-34a/miR-34c decreased cell viability, migration ability, and invasiveness, while differentially affecting the expression of genes involved in survival, cell progression, proliferation, cell cycle arrest or death, and EMT promotion, depending on the miRNA and cell line.
conclusionsmiR-34a and miR-34c are multifunctional tumor suppressors that play an important regulatory role in pHGG-4 aggressiveness. Both miRNAs can serve as excellent and powerful therapeutic tools against pHGG-4. IMPACT: This study revealed miR-34a and miR-34c as multifunctional suppressors of pHGG-4 tumor aggressiveness, both downregulated in disease models. miR-34a/miR-34c restoration decreased cell viability, migration ability, invasiveness, and stemness marker expression Both miRNAs exerted similar phenotypic effects while differentially regulated gene expression in a miRNA-associated and cell line-dependent manner The findings reinforced that epigenetic dysregulation, rather than recurrent genetic alterations, is a central driver of pHGG-4 aggressiveness. This work suggests the rational for potential miR-34-based therapeutic strategies in this otherwise incurable disease.
Identifiers
42850359What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.